Picture of Mesa Laboratories logo

MLAB — Mesa Laboratories News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Mesa Laboratories Inc reports results for the quarter ended in September - Earnings Summary

* Mesa Laboratories Inc  MLAB.OQ  reported quarterly
adjusted
earnings of 24 cents​​ per share for the quarter ended in
September. The mean expectation of three analysts for the
quarter was for a loss of 31 cents per share.
    * Revenue rose 63.9% to $58.75 million from a year ago;
analysts
expected $53.30 million. 
    * The mean earnings estimate of analysts had fallen by
about 126.8% in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Mesa Laboratories Inc shares had fallen by 9.1% this
quarter and
lost 61.0% so far this year.
    * Wall Street's median 12-month price target for Mesa
Laboratories
Inc is $180.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
3 at 01:04 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.31          0.24           Beat
 Jun. 30 2022      1.00           -0.27          Missed
 Mar. 31 2022      0.48           -0.34          Missed
 Dec. 31 2021      0.42           0.61           Beat

Recent news on Mesa Laboratories

See all news